Skip to main content
NewslettersWatchlist

Newmarket Corp(NEU-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low552.87
Day High563.96
Open:556.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
The Globe and Mail
11 U.S. mid-cap stocks with attractive valuations
Barchart
Did You Know These 3 Dividend Growth Stocks Are up Over 80%?
Barchart
Chart of the Day: NewMarket - ICE Performance Enhancement Products
Business Wire
NewMarket Corporation Increases Quarterly Dividend
Business Wire
NewMarket Corporation Reports First Quarter 2023 Results
Business Wire
NewMarket Corporation Schedules Conference Call and Webcast to Review First Quarter 2023 Financial Results
Business Wire
Acadia Pharmaceuticals Announces U.S. FDA Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome in Adult and Pediatric Patients Two Years of Age and Older
Business Wire
NewMarket Corporation Declares Quarterly Dividend
Business Wire
NewMarket Corporation Reports Fourth Quarter and Full Year 2022 Results
Business Wire
NewMarket Corporation Schedules Conference Call and Webcast to Review Fourth Quarter and Full Year 2022 Financial Results
Business Wire
NewMarket Announces the Retirement of the President of Afton Chemical Corporation and the Appointment of New President
Business Wire
NewMarket Corporation Declares Quarterly Dividend
Business Wire
NewMarket Corporation Reports Third Quarter and First Nine Months 2022 Results
Business Wire
NewMarket Corporation Schedules Conference Call and Webcast to Review Third Quarter 2022 Financial Results
Business Wire
Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA
Business Wire
NewMarket Corporation Declares Quarterly Dividend
Business Wire
NewMarket Corporation Releases ESG 2021 Report
Business Wire
NewMarket Corporation Reports Second Quarter and First Half 2022 Results
Business Wire
Afton Chemical Continues to Invest in Capabilities to Meet Growing Market Needs in Transmission Fluids and Electric Vehicles
Business Wire
Acadia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Trofinetide for the Treatment of Rett Syndrome
Business Wire
NewMarket Corporation Schedules Conference Call and Webcast to Review Second Quarter 2022 Financial Results
Business Wire
NewMarket Corporation Declares Quarterly Dividend

Profile

NewMarket Corporation through its subsidiaries, Afton Chemical Corporation and Ethyl Corporation, develops, manufactures, blends, and delivers chemical additives that enhance the performance of petroleum products. From custom-formulated chemical blends to market-general additive components, the NewMarket family of companies provides the world with the technology to make fuels burn cleaner, engines run smoother and machines last longer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.